cellceutix is an emerging bio-pharmaceutical company
focusing in the areas of cancer
and inflammatory disease...
Press Release 11/7/2011

Cellceutix Files Investigational New Drug Application (IND) with FDA, Clinical Trials Planned at Dana-Farber/Harvard Cancer Center
 
 
You are not authorised to view this resource.

You need to login.
 
KM 391 - Autism Compound
Product Pipeline
Kevetrin™ - Our lead compound
KM 133 - Psoriasis Compound